Sunday 5th February, 2012   |   Welcome, guest. Please, login or register  
Sunday November 15, 10:52

A vaccine against malaria within three years?

Malaria kills over one million people annually worldwide, mostly children under five and pregnant women, especially in sub-Saharan Africa where one child dies every 30 seconds as a result of the disease
Malaria kills over one million people annually worldwide, mostly children under five and pregnant women, especially in sub-Saharan Africa where one child dies every 30 seconds as a result of the disease
 

A vaccine against malaria, including the final test phase has been underway since May in seven African countries, could be licensed within three to five years, said scientists, meeting in conference in Nairobi.

On the third day of their discussions, nearly a thousand participants at the 5th Conference of the Multilateral Initiative on Malaria (MIM) have evaluated the progress of current research on vaccine RTS, S, developed in partnership between the Malaria Vaccine Initiative (MVI) and GlaxoSmithKline Biologicals (GSK Bio).

The results of phase 2 of vaccine trial, published last year, showed an efficiency of 53% in young children affected by the disease.

The third phase of clinical trials is underway since May in seven African countries (Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique, Tanzania), involving 16,000 children aged six weeks to 17 months.

It evaluates side effects of the future vaccine, intended primarily for infants and children under five years, who are the most vulnerable to malaria.

"It is an extraordinary moment in the fight against malaria, and the highlight of more than two decades of research, including ten years of clinical trials in Africa," said Dr. Joe Cohen, co-inventor of vaccine RTS, S and researcher at GSK Bio.

Malaria kills over one million people annually worldwide, mostly children under five and pregnant women, especially in sub-Saharan Africa where one child dies every 30 seconds as a result of the disease.

 
Rate:
  •  
Please, login to rate the article.
 
 

Recommended articles:

 

HIV/AIDS: New tests needed for vaginal gel

Two additional clinical testing will be conducted to confirm the effectiveness of vaginal microbicide gel
Two additional clinical testing will be conducted to confirm the effectiveness of vaginal microbicide gel that is supposed to greatly reduce the risk of transmission of HIV/AIDS, said Friday the United Nations Joint Programme on HIV/AIDS (UNAIDS).
 

Diarrhea: The Grim Reaper's Crop

Babies who are not breastfed during the first six months of life are six times more likely to die of infectious diseases, including diarrhea
Approximately 1.5 million children die each year from diarrheal diseases according to a report issued Wednesday afternoon by UNICEF and the World Health Organization (WHO).
 

Malaria: A promising discovery

Malaria has since been the subject of much research, but the parasite that causes the disease demonstrated a great ability to rapidly develop resistance to antimalarial drugs
The National Institute of Health and Medical Research (Inserm) announced a breakthrough in the fight against malaria. Transmitted by certain species of mosquitoes, malaria affects about 250 million people worldwide and kills between one and three million.
 

Most recent in the category Deseases:

 
 
 

Last comments

 

No comments. Be the first to comment the article!

Please, login to post comments.
 
 
 
 

Home | Social Health | AIDS | Cancer | Deseases | Diet | Human body | Most read | Top rated

RSS | Feedback | Headlines for your website | Terms of Service/Privacy policy

Copyright © 2012 Heal-all.org. All rights reserved.